QuantumScape Co. (NYSE:QS – Get Free Report) Director Jagdeep Singh sold 5,531 shares of the stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $5.01, for a total transaction of $27,710.31. Following the completion of the transaction, the director now owns 2,590,583 shares of the company’s stock, valued at $12,978,820.83. This trade represents a 0.21 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Jagdeep Singh also recently made the following trade(s):
- On Monday, October 7th, Jagdeep Singh sold 192,270 shares of QuantumScape stock. The stock was sold at an average price of $5.53, for a total value of $1,063,253.10.
- On Tuesday, September 17th, Jagdeep Singh sold 192,270 shares of QuantumScape stock. The shares were sold at an average price of $5.99, for a total value of $1,151,697.30.
QuantumScape Stock Down 2.3 %
Shares of QuantumScape stock opened at $4.74 on Monday. QuantumScape Co. has a 12-month low of $4.67 and a 12-month high of $10.03. The firm has a market capitalization of $2.43 billion, a PE ratio of -4.99 and a beta of 4.60. The company has a quick ratio of 14.07, a current ratio of 14.07 and a debt-to-equity ratio of 0.03. The stock’s fifty day moving average is $5.49 and its 200-day moving average is $5.76.
Institutional Investors Weigh In On QuantumScape
A number of large investors have recently made changes to their positions in QS. Vanguard Group Inc. lifted its stake in QuantumScape by 2.2% in the 1st quarter. Vanguard Group Inc. now owns 30,484,915 shares of the company’s stock worth $191,750,000 after acquiring an additional 656,646 shares in the last quarter. Canada Pension Plan Investment Board purchased a new stake in shares of QuantumScape in the second quarter worth approximately $1,950,000. American Century Companies Inc. boosted its holdings in shares of QuantumScape by 880.6% during the second quarter. American Century Companies Inc. now owns 352,286 shares of the company’s stock worth $1,733,000 after purchasing an additional 316,361 shares during the period. Geode Capital Management LLC grew its position in QuantumScape by 3.9% during the third quarter. Geode Capital Management LLC now owns 5,853,958 shares of the company’s stock valued at $33,671,000 after purchasing an additional 218,743 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale acquired a new position in QuantumScape in the 1st quarter valued at approximately $1,002,000. Institutional investors and hedge funds own 29.87% of the company’s stock.
Analyst Upgrades and Downgrades
QS has been the subject of several research analyst reports. Wolfe Research initiated coverage on QuantumScape in a report on Thursday, September 5th. They issued an “underperform” rating for the company. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $6.00 price target on shares of QuantumScape in a report on Tuesday, September 10th. Finally, Truist Financial reaffirmed a “hold” rating and issued a $7.00 price objective (up previously from $6.00) on shares of QuantumScape in a research note on Friday, October 25th. Two investment analysts have rated the stock with a sell rating and five have issued a hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $6.14.
QuantumScape Company Profile
QuantumScape Corporation, a research and development stage company, focuses on the development and commercialization of solid-state lithium-metal batteries for electric vehicles and other applications. The company was founded in 2010 and is headquartered in San Jose, California.
Featured Articles
- Five stocks we like better than QuantumScape
- How to buy stock: A step-by-step guide for beginners
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Stock Sentiment Analysis: How it Works
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Quiet Period Expirations Explained
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for QuantumScape Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QuantumScape and related companies with MarketBeat.com's FREE daily email newsletter.